
IHH 5225
PREV | CLOSE | CHANGE | HIGH | CLOSE |
---|---|---|---|---|
5.350 | 5.280 | -0.070 | 5.400 | 5.230 |
VOLUME | BUY VOL | BUY | SELL | SELL VOL |
---|---|---|---|---|
18,218 | 42 | 5.280 | 5.320 | 90 |
52 Weeks Range : 4.55 - 5.94
PREV | CLOSE | CHANGE | HIGH | CLOSE |
---|---|---|---|---|
5.350 | 5.280 | -0.070 | 5.400 | 5.230 |
VOLUME | BUY VOL | BUY | SELL | SELL VOL |
---|---|---|---|---|
18,218 | 42 | 5.280 | 5.320 | 90 |
BURSA MALAYSIA –
The Group reported a 28% and 64% quarter-on-quarter decrease in revenue and EBITDA respectively as a result of the COVID-19 pandemic.
BURSA MALAYSIA –
The Group reported a 7% and 19% quarter-on-quarter decrease in revenue and EBITDA respectively as a result of the COVID-19 pandemic in Q1 2020. EBITDA decreased from a high base when the Group recorded RM11.4 million revaluation gain on PLife REIT’s investment properties in Q4 2019.
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 63.03 million. It was slightly low compared to average in listed companies, considering the employees’ remuneration of 5371.5 million and auditor’s remuneration of 1254 thousands
INVESTING MALAYSIA –
21 JAN 20 – London Stock Exchange (LSE)-listed Symphony International Holding Ltd has fully exited its investment in IHH Healthcare Bhd.
INVESTING MALAYSIA –
IHH (6 JAN 20) IHH shares took a hit in early trading today as geopolitical tension in the Middle East soared following the killing of an Iranian general in Baghdad, Iraq last week.
Investing Malaysia –
Average investing volume for IHH Healthcare Bhd in the past three months in stock market was 4502.7k lots
Investing Malaysia –
IHH gets a score of 7.28 in our equity and assets quality test based on current share price of RM5.74
Investing Malaysia –
IHH Healthcare Bhd gets a score of 14.89 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 5225 in Bursa Malaysia declared adjusted 0.52% dividend yield in past few years
Investing Malaysia –
IHH is estimated to have a profit consensus of 1123.43 millions, with an adjusted market capitalization of 49134.35 millions
REMUNERATION STUDY –
In Financial Year End 2018, the directors’ remuneration was 48.64 million. It was slightly low compared to average in listed companies, considering the employees’ remuneration of 4538.1 million and auditor’s remuneration of 1212 thousands